Structure_NN
and_CC
function_NN
analysis_NN
of_IN
the_DT
human_JJ
myeloid_JJ
cell_NN
nuclear_JJ
differentiation_NN
antigen_NN
promoter_NN
:_:
evidence_NN
for_IN
the_DT
role_NN
of_IN
Sp1_NN
and_CC
not_RB
of_IN
c-Myb_NN
or_CC
PU_NN
.1_CD
in_IN
myelomonocytic_JJ
lineage-specific_JJ
expression_NN
._.

The_DT
human_JJ
myeloid_JJ
nuclear_JJ
differentiation_NN
antigen_NN
-LRB-_-LRB-
MNDA_NN
-RRB-_-RRB-
is_VBZ
expressed_VBN
specifically_RB
in_IN
maturing_VBG
cells_NNS
of_IN
the_DT
myelomonocytic_JJ
lineage_NN
and_CC
in_IN
monocytes_NNS
and_CC
granulocytes_NNS
._.

Epitope_NN
enhancement_NN
was_VBD
used_VBN
to_TO
confirm_VB
the_DT
strict_CD
lineage_NN
-_:
and_CC
stage-specific_JJ
expression_NN
of_IN
MNDA_NN
in_IN
bone_NN
marrow_NN
as_RB
well_RB
as_IN
in_IN
other_JJ
paraffin-embedded_JJ
fixed_JJ
tissues_NNS
._.

A_DT
1-kb_JJ
region_NN
of_IN
the_DT
gene_NN
that_WDT
includes_VBZ
5_CD
'_POS
flanking_NN
sequence_NN
was_VBD
reported_VBN
earlier_RBR
to_TO
contain_VB
functional_JJ
promoter_NN
activity_NN
and_CC
was_VBD
specifically_RB
demethylated_VBN
in_IN
expressing_VBG
cells_NNS
in_IN
contrast_NN
to_TO
null_JJ
cells_NNS
._.

Further_RB
analysis_NN
has_VBZ
revealed_VBN
that_IN
this_DT
1-kb_JJ
fragment_NN
promotes_VBZ
higher_JJR
reporter_NN
gene_NN
activity_NN
in_IN
MNDA-expressing_JJ
cells_NNS
than_IN
non-expressing_JJ
cells_NNS
,_,
indicating_VBG
cell-specific_JJ
differences_NNS
in_IN
transactivation_NN
._.

This_DT
sequence_NN
contains_VBZ
consensus_NN
elements_NNS
consistent_JJ
with_IN
myeloid-specific_JJ
gene_NN
expression_NN
,_,
including_VBG
a_DT
PU_NN
.1_CD
consensus_NN
site_NN
near_IN
the_DT
major_JJ
transcription_NN
start_NN
site_NN
and_CC
a_DT
cluster_NN
of_IN
c-Myb_NN
sites_NNS
located_JJ
several_JJ
hundred_CD
bases_NNS
upstream_RB
of_IN
this_DT
region_NN
._.

However_RB
,_,
analysis_NN
of_IN
deletion_NN
mutants_NNS
localized_VBD
nearly_RB
all_DT
of_IN
the_DT
promoter_NN
activity_NN
to_TO
a_DT
short_JJ
region_NN
-LRB-_-LRB-
-73_CD
to_TO
-16_CD
-RRB-_-RRB-
that_WDT
did_VBD
not_RB
include_VB
the_DT
cluster_NN
of_IN
c-Myb_NN
sites_NNS
._.

A_DT
4-bp_JJ
mutation_NN
of_IN
the_DT
core_NN
Sp1_NN
consensus_NN
element_NN
-LRB-_-LRB-
GC_NN
box_NN
-RRB-_-RRB-
-LRB-_-LRB-
-20_CD
-RRB-_-RRB-
reduced_VBD
overall_JJ
promoter_NN
activity_NN
of_IN
the_DT
1-kb_JJ
fragment_NN
._.

Mutation_NN
of_IN
the_DT
PU_NN
.1_CD
site_NN
did_VBD
not_RB
significantly_RB
affect_VB
promoter_NN
activity_NN
._.

Only_RB
a_DT
small_JJ
region_NN
-LRB-_-LRB-
-35_CD
to_TO
+22_CD
-RRB-_-RRB-
including_VBG
the_DT
Sp1_NN
element_NN
and_CC
transcription_NN
start_NN
site_NN
,_,
but_CC
not_RB
the_DT
PU_NN
.1_CD
site_NN
was_VBD
footprinted_VBN
._.

The_DT
4-bp_JJ
mutation_NN
of_IN
the_DT
core_NN
Sp1_NN
consensus_NN
element_NN
abolished_VBD
footprinting_NN
at_IN
the_DT
site_NN
and_CC
an_DT
antibody_NN
super-shift_JJ
reaction_NN
showed_VBD
that_IN
Sp1_NN
is_VBZ
one_CD
of_IN
the_DT
factors_NNS
binding_VBG
the_DT
consensus_NN
site_NN
._.

The_DT
Sp1_NN
site_NN
also_RB
co-localizes_VBZ
with_IN
a_DT
DNase_NN
I_CD
hypersensitive_JJ
site_NN
._.

The_DT
results_NNS
indicate_VBP
that_IN
DNA_NN
methylation_NN
,_,
chromatin_NN
structure_NN
,_,
and_CC
transactivation_NN
at_IN
an_DT
Sp1_NN
site_NN
contribute_VBP
to_TO
the_DT
highly_RB
restricted_VBN
expression_NN
of_IN
this_DT
myelomonocytic_JJ
lineage_NN
specific_JJ
gene_NN
._.

